The biopsies from the Type II diabetes patients also demonstrate significant reduction of GLUT4 and activation of PI3K/Akt signaling pathways at sarcolemma in diabetic mice and patients with non-insulin-dependent diabetes mellitus. This evidence concerns the gene AKT1 and diabetes mellitus.